Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K McElhone

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|December 16, 1998
GMDP and psoriasisM Bhushan, K McElhone, C E Griffiths
Lupus|November 24, 2006
A review of health related quality of life in systemic lupus erythematosusK McElhone, J Abbott, L S Teh
Lupus|August 17, 2010
Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative studyK McElhone, J Abbott, J Gray, et al.
The British Journal of Dermatology|November 13, 2001
Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled studyM Bhushan, A D Burden, K McElhone, et al.
The British Journal of Dermatology|December 21, 2004
Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-beingD G Fortune, H L Richards, B Kirby, et al.
Clinical Endocrinology|November 26, 1998
The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in womenH M Buckler, K McElhone, P N Durrington, et al.
Annals of the Rheumatic Diseases|January 8, 2009
Lupus-specific health outcome measure for US patients: the LupusQoL-US versionM Jolly, A S Pickard, C Wilke, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
The British Journal of Dermatology|April 4, 2017
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasisI Y K Iskandar, D M Ashcroft, R B Warren, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|December 16, 1998
GMDP and psoriasisM Bhushan, K McElhone, C E Griffiths
Lupus|November 24, 2006
A review of health related quality of life in systemic lupus erythematosusK McElhone, J Abbott, L S Teh
Lupus|August 17, 2010
Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative studyK McElhone, J Abbott, J Gray, et al.
The British Journal of Dermatology|November 13, 2001
Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled studyM Bhushan, A D Burden, K McElhone, et al.
The British Journal of Dermatology|December 21, 2004
Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-beingD G Fortune, H L Richards, B Kirby, et al.
Clinical Endocrinology|November 26, 1998
The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in womenH M Buckler, K McElhone, P N Durrington, et al.
Annals of the Rheumatic Diseases|January 8, 2009
Lupus-specific health outcome measure for US patients: the LupusQoL-US versionM Jolly, A S Pickard, C Wilke, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
The British Journal of Dermatology|April 4, 2017
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasisI Y K Iskandar, D M Ashcroft, R B Warren, et al.
Pageof 2